Galactooligosaccharides Patent Landscape
Identifiers
Functions
Which organizations and claims shape current development around galactooligosaccharides?
The sole patent is assigned to an individual inventor, 杨伟学, indicating that current development is driven by individual inventors rather than large corporations. The claims focus on a traditional Chinese medicine composition for assisting microplastic and nanoplastic removal, with galactooligosaccharides as an optional component in an intestinal health group. The claims cover multiple dosage forms and optional functional groups, including heavy metal removal and beauty/anti-aging, suggesting a broad intellectual property strategy. This highlights a trend toward personalized or multi-benefit formulations in the functional food space.
How is Galactooligosaccharides innovation changing?
Monthly patent filings
Which technical problems do recent patents address with galactooligosaccharides?
Recent patent evidence positions galactooligosaccharides within a formulation aimed at assisting removal of microplastics and nanoplastics from the body, specifically as part of an intestinal health group. The technical problem addressed is toxin clearance, with the ingredient contributing to gut-related support rather than being the primary active. The patent claims a traditional Chinese medicine composition with optional functional groups, where galactooligosaccharides appear only as an optional additive. This suggests a claimed role in digestive function within a broader detoxification context, not a standalone solution.
How do recent patents change the role or application of galactooligosaccharides?
The patent changes galactooligosaccharides' role from a primary prebiotic to a secondary, optional component in a multi-functional detoxification composition. It is grouped with fructooligosaccharides in an intestinal health group, suggesting a shift toward combination use for gut support within traditional Chinese medicine frameworks. This indicates a potential repositioning as an adjunct to herbal ingredients rather than a standalone active. The application is for a functional food or pharmaceutical dosage form, expanding its possible use beyond conventional dairy or supplement products.
Which product categories feature Galactooligosaccharides in recent patents?
How is Galactooligosaccharides used in recent patents?
Which product categories and formulation strategies emerge in recent work on galactooligosaccharides?
Emerging formulation strategies include incorporating galactooligosaccharides into traditional Chinese medicine compositions for toxin removal, with dosage forms ranging from decoctions and oral liquids to gummies and meal replacement shakes. The ingredient is part of an optional intestinal health group, combined with fructooligosaccharides, within a larger product that targets microplastic and nanoplastic clearance. This suggests a strategy of adding prebiotics to herbal detoxification products to support gut health, potentially enhancing consumer appeal in functional foods and beverages. The patent also emphasizes self-extraction of active ingredients, indicating a focus on natural processing.
Which recent patents are most relevant to Galactooligosaccharides?
A traditional Chinese medicine composition for assisting in the removal of microplastics and nanoplastics from the body, and its preparation methods and applications in multiple dosage forms.
intestinal health group
Where is the evidence-backed white space for further development of galactooligosaccharides?
Evidence-backed white space exists in combining galactooligosaccharides with traditional Chinese medicine ingredients for detoxification, particularly in dosage forms like oral sprays and meal replacement shakes. The patent's optional intestinal health group suggests room for developing products that pair prebiotics with herbal extracts for gut health within toxin-removal contexts. However, the lack of explicit galactooligosaccharide claims in the patent indicates an opportunity to establish its specific functional contribution. Further research could explore synergistic effects with fructooligosaccharides and other functional groups, but current evidence is too limited to define clear market gaps.